Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death

Kuo Liang Wei, Fei Yun Chen, Chih Yi Lin, Guan Lun Gao, Wen Ya Kao, Chi Hui Yeh, Chang Rong Chen, Hao Chun Huang, Wei Ren Tsai, Koa Jen Jong, Wan Jung Li, Jyan Gwo Joseph Su*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

13 Scopus citations


Carbendazim inhibits microtubule assembly, thus blocking mitosis and inhibiting cancer cell proliferation. Accordingly, carbendazim is being explored as an anticancer drug. Data show that carbendazim increased mRNA and protein expressions and promoter activity of CYP1A1. In addition, carbendazim activated transcriptional activity of the aryl hydrocarbon response element, and induced nuclear translocation of the aryl hydrocarbon receptor (AhR), a sign the AhR is activated. Carbendazim-induced CYP1A1 expression was blocked by AhR antagonists, and was abolished in AhR signal-deficient cells. Results demonstrated that carbendazim activated the AhR, thereby stimulating CYP1A1 expression. In order to understand whether AhR-induced metabolic enzymes turn carbendazim into less-toxic metabolites, Hoechst 33342 staining to reveal carbendazim-induced nuclear changes and flow cytometry to reveal the subG0/G1 population were applied to monitor carbendazim-induced cell apoptosis. Carbendazim induced less apoptosis in Hepa-1c1c7 cells than in AhR signal-deficient Hepa-1c1c7 mutant cells. Pretreatment with β-NF, an AhR agonist that highly induces CYP1A1 expression, decreased carbendazim-induced cell death. In addition, the lower the level of AhR was, the lower the vitality present in carbendazim-treated cells, including hepatoma cells and their derivatives with AhR RNA interference, also embryonic kidney cells, bladder carcinoma cells, and AhR signal-deficient Hepa-1c1c7 cells. In summary, carbendazim is an AhR agonist. The toxicity of carbendazim was lower in cells with the AhR signal. This report provides clues indicating that carbendazim is more potent at inducing cell death in tissues without than in those with the AhR signal, an important reference for applying carbendazim in cancer chemotherapy.

Original languageEnglish
Pages (from-to)86-97
Number of pages12
JournalToxicology and Applied Pharmacology
StatePublished - 01 09 2016

Bibliographical note

Publisher Copyright:
© 2016


  • Aryl hydrocarbon receptor
  • Carbendazim
  • Cytochrome P450


Dive into the research topics of 'Activation of aryl hydrocarbon receptor reduces carbendazim-induced cell death'. Together they form a unique fingerprint.

Cite this